iBio Stock (AMEX:IBIO), Quotes and News Summary

Q: What sector and industry does iBio (IBIO) operate in?

iBio is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

iBio Stock (AMEX: IBIO) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	19.000 / 3.774M
Day Range	- - -
52 Wk Range	1.021 - 28.200
Market Cap	$16.276M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	49
Short Interest	1.88%
Days to Cover	1

Recent News

Micro-Cap Stock iBio Doubles On Wednesday - Here's Why

iBio surged after collaborating with AstralBio Inc. to develop antibodies for obesity & cardiometabolic conditions. Shares soared over 100%, hitting $2.44. Collaboration aims to target TGFb superfamily for muscle wasting & obesity treatment.

Vandana Singh

Top 4 Health Care Stocks That May Rocket Higher In Q1

The most oversold stocks in the health care presents an opportunity to buy into undervalued companies.

Avi Kapoor

Crude Oil Moves Lower; AutoZone Profit Tops Views

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on Tuesday. The Dow traded down 0.18% to 36,138.19 while the NASDAQ rose 0.19% to 14,212.19. The S&P 500 also fell, dropping, 0.07% to 4,566.73.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

1.5

Strong Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

About iBio Inc

Sector

Health Care

Industry

Biotechnology

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and pr...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy iBio (IBIO) stock?

You can purchase shares of iBio (AMEX: IBIO) through any online brokerage.

View our list of the best stock brokerages.

Who are iBio's (IBIO) competitors?

Other companies in iBio’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and T2 Biosystems (NASDAQ:TTOO).

What is the target price for iBio (IBIO) stock?

The latest price target for iBio (AMEX: IBIO) was reported by JMP Securities on Thursday, February 16, 2023. The analyst firm set a price target for 0.00 expecting IBIO to fall to within 12 months (a possible NaN% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for iBio (IBIO)?

The stock price for iBio (AMEX: IBIO) is $ last updated .

Does iBio (IBIO) pay a dividend?

There are no upcoming dividends for iBio.

When is iBio (AMEX:IBIO) reporting earnings?

iBio’s Q3 earnings are confirmed for Monday, May 13, 2024.

Is iBio (IBIO) going to split?

There is no upcoming split for iBio.

What sector and industry does iBio (IBIO) operate in?

iBio is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

-

-

-

-

-

-

-

-

-

-

-

-

-

-